Redeye comments on Lime’s Q1 2026 report, which showed an acceleration in ARR growth alongside a sol...
Aspo reports Q1 results on Apr 27. We believe FY’26 EBITA will improve by at least some amount thank...
Redeye updates its estimates and fair value range following Waystream’s Q1 report, which came in sof...
Ahead of Taaleri's Q1 results on 29 April, we make several estimate changes.
As expected, Careium has been selected as part of the new Digital Security Services framework for or...
Mr. Cavander will start in his new role on 8 May 2026.
EUZ Q1 26 results are due on May 12. We expect sales of € 72.
* Positive PW: Adj. EBITA +36% vs ABG (mid-point) * Temporary boost from memory crisis and positive ...
We expect modest revenue growth in Q1, supported by project completions, but with some near-term mar...
Vi ser att kvartal-för-kvartal-fallet i värderingar för mjukvaru- och marknadsplatsjämförelsebolag s...
We see the q/q drop in valuation for software and marketplace peers creating a soft backdrop for VNV...
* Liten Q1e: +10 % intäktstillväxt, EBITDA på DKK -3,2m* Tyska utrullningar enligt plan; vi ligger k...
AVTECH's Q1 2026 key figures, published ahead of the full report on 24 April, revealed a sequential ...
Vi lämnar våra prognoser i stort sett oförändrade inför Nellys Q1.
We leave our estimates largely unchanged ahead of Nelly’s Q1.
Redeye comments on Initiator Pharma’s announcement that it will discontinue development of IP2018 an...
Steyr Motors reported final 2025 results in line with prelims, confirmed its 2026 guidance and provi...
Following a quiet March, the Top Picks Investment Committee is putting our cash pile to work.
Redeye comments on Avensia’s preliminary sales figures for March 2026, causing a slight increase in ...
Yesterday, NFON published its FY25 annual report, confirming the preliminary figures released in Feb...
